Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART).

Michele PighiFabrizio TomaiSimone FezziGabriele PesariniAlessandro PetroliniLeonardo SpedicatoGiuseppe TarantiniMarco FerliniPaolo CalabròBruno LoiValeria FerreroMaria Natalia Tovar ForeroJoost DaemenFlavio Ribichini

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2024)

BRS-based PCI for the treatment of CAV is feasible and safe, with an ISSR incidence similar to what reported in retrospective studies with drug-eluting stents.

Keyphrases

coronary artery disease
percutaneous coronary intervention
risk factors
acute myocardial infarction
cross sectional
atrial fibrillation
st segment elevation myocardial infarction
st elevation myocardial infarction
tissue engineering
case control
coronary artery bypass grafting